478只股公布截至5月10日最新股东户数，相比上期股东户数下降的有177只，降幅居前的是*ST声迅、 金杨股份、恒勃股份等。 投资者除了在定期报告中获得股东信息数据外，还可以在交易所互动平台上通过提问方式了解部分公司 更及时（每月10日、20日、月末）的股东户数信息。以往3期分别有578家、963家、920家公司在互动平 台透露了股东户数，截至发稿，共有478家公司公布了截至5月10日股东户数。 上期筹码集中股回测：62%跑赢沪指 证券时报·数据宝对上一期(4月30日)筹码集中股监测显示，这些股4月21日以来平均上涨6.28%，走势强 于同期沪指表现（上涨3.18%），其中，62%的筹码集中股相对大盘获超额收益。 上期股东户数降逾一成个股中，山水比德涨幅最高，4月21日以来累计上涨48.16%，涨幅居前的还有 *ST和科、中超控股等。 6股最新股东户数降逾一成 市场表现方面，最新一期筹码集中股5月1日以来平均上涨4.38%，涨幅居前的有*ST和科、*ST兰黄、保 税科技等，分别上涨36.11%、25.45%、19.60%。所属行业来看，筹码集中股中机械设备、医药生物、 基础化工等行业最为集中，分别有16只、1 ...

Company Overview - Dongxing Medical's closing price on May 14 was 24.49 yuan, an increase of 2.08%, with a rolling PE ratio of 27.38, marking a new low in 37 days, and a total market capitalization of 2.453 billion yuan [1] - The company specializes in the research, production, and sales of surgical medical devices, with main products including endoscopic staplers, open staplers, stapler components, electric hydraulic surgical tables, shadowless surgical lights, and delivery beds [1] Financial Performance - In the first quarter of 2025, Dongxing Medical reported operating revenue of 78.1865 million yuan, a year-on-year decrease of 14.84%, and a net profit of 12.064 million yuan, down 39.35% year-on-year, with a gross profit margin of 44.40% [1] Shareholder Information - As of May 9, 2025, Dongxing Medical had 10,593 shareholders, a decrease of 35 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 49.84, with a median of 36.65, placing Dongxing Medical at the 61st position in the industry ranking [2]

Group 1 - The core viewpoint of the articles highlights Huamao Logistics' current market performance, including its stock price increase and market capitalization [1] - As of May 13, Huamao Logistics closed at 6.58 yuan, up 2.17%, with a rolling PE ratio of 17.58 times and a total market value of 8.614 billion yuan [1] - The average PE ratio for the logistics industry is 24.31 times, with a median of 22.95 times, positioning Huamao Logistics at the 27th rank within the industry [1] Group 2 - As of March 31, 2025, Huamao Logistics had 56,447 shareholders, an increase of 1,917 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in third-party international comprehensive logistics and provides various logistics services, including international air and sea freight, cross-border e-commerce logistics, and special logistics [1] - Huamao Logistics ranked 16th in the latest global shipping and air freight forwarders list published by Transport Topics, indicating its competitive position in the international logistics market [1] Group 3 - In the first quarter of 2025, Huamao Logistics reported a revenue of 3.992 billion yuan, a year-on-year increase of 2.82%, while net profit was 118 million yuan, reflecting a year-on-year decrease of 29.42%, with a gross profit margin of 11.39% [1]

Group 1 - The core viewpoint of the article highlights Chengdu Xian Dao's current stock performance, with a closing price of 15.82 yuan, an increase of 1.54%, and a rolling PE ratio of 96.48, marking a new low in 20 days, with a total market value of 6.339 billion yuan [1] - Chengdu Xian Dao ranks 40th in the medical services industry based on PE ratio, which has an average of 38.66 and a median of 38.36 [1] - As of March 31, 2025, the number of shareholders for Chengdu Xian Dao has increased to 16,254, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - The main business of Chengdu Xian Dao includes drug early discovery and development services related to DEL technology, offering services such as DEL screening, DEL library customization, FBDD/SBDD, custom drug development, compound structure intellectual property transfer, and chemical synthesis [1] - In the latest quarterly report for Q1 2025, the company achieved an operating income of 107 million yuan, a year-on-year decrease of 0.60%, while net profit reached 28.2844 million yuan, a year-on-year increase of 102.90%, with a gross profit margin of 51.87% [1]

Group 1 - The core viewpoint of the articles highlights that Lepu Medical's stock closed at 11.41 yuan, with a PE ratio of 149.42, marking a new low in 20 days, and a total market capitalization of 21.458 billion yuan [1] - The average PE ratio for the medical device industry is 48.90, with a median of 36.41, positioning Lepu Medical at the 111th rank within the industry [1] - As of March 31, 2025, Lepu Medical has 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management, with its primary products being in these categories [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44%, with a gross profit margin of 64.03% [1] - The PE ratios for Lepu Medical are significantly higher than the industry averages, indicating potential overvaluation compared to peers [2]

Group 1 - The core business of the company is the research, production, and sales of mid-to-high-end CNC machine tools, including large machining centers, vertical CNC machine tools, and horizontal CNC machine tools [2] - As of March 31, 2025, the company had 11,793 shareholders, a decrease of 431 from the previous period, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The company achieved a revenue of 569 million yuan in the first quarter of 2025, representing a year-on-year increase of 3.80%, while net profit was 61.36 million yuan, a year-on-year decrease of 11.78%, with a gross profit margin of 21.11% [2] Group 2 - The company's current price-to-earnings (PE) ratio is 19.84, compared to the industry average of 75.41 and the industry median of 38.33, ranking 68th in the industry [1][3] - The company has received multiple honors, including recognition as a Jiangsu Province Intelligent Manufacturing Factory and a Jiangsu Province Five-Star Cloud Enterprise, among others [2] - The company has been awarded the CNAS certificate for its testing laboratory, indicating compliance with national standards [2]